All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @findingkerryagain on TikTok · 108s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @findingkerryagain's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Come do my third dose of ozumbic with me. So here I am
  2. 0:05Just getting my pen ready as you can see I'm using the 0.25 milligram dose
  3. 0:12I am
  4. 0:14Clicking it to 0.25
  5. 0:18There you go as you can see and
  6. 0:21Then I am about to prep the needle top so I'm getting my
  7. 0:27New
  8. 0:28Neel top out from the box and I am
  9. 0:32Putting it on to the pen
  10. 0:34Still getting used to this so
  11. 0:37You can see I struggle with it a little bit
  12. 0:42And then I am going to
  13. 0:47Take off the first top. Nope first. I am going to prep the area. I've been injecting in my stomach
  14. 0:54I just have felt that that's been best for me
  15. 0:57I
  16. 0:59Switch sides every second week and I'm just swabbing down with some alcohol
  17. 1:04to clean the area and
  18. 1:09I am removing the second top from and the pen
  19. 1:14I'm going to grab my stomach that and
  20. 1:18I'm going to stick it in
  21. 1:21There we go
  22. 1:23Just want to make sure that the numbers facing me so I can see it go down
  23. 1:28I'm pushing it in until you hear the click
  24. 1:32And
  25. 1:33Then I'm holding it for an extra six seconds one two three four five six
  26. 1:41couple extra seconds just to make sure it's really in there and
  27. 1:45That is it. It's a pretty simple process

@findingkerryagain's Ozempic dosing walkthrough, fact-checked

Finding Kerry

TikTok creator

70.1K viewsWatch on TikTok

Quick answer

The creator is following a standard semaglutide initiation protocol, using the recommended 0.25 mg weekly starting dose before escalating to 0.5 mg at week five, consistent with the FDA-approved Ozempic dosing schedule. The hashtag use of #compoundsemaglutide alongside #ozempic introduces uncertainty about whether the product shown is a regulated branded pen or a compounded formulation, which carry different regulatory and quality assurance considerations. Injection technique is largely appropriate, though the described two-week site alternation interval is less frequent than most clinical guidance recommends for preventing lipohypertrophy.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @findingkerryagain's Ozempic dosing walkthrough, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@findingkerryagain's Ozempic dosing walkthrough, fact-checked" from Finding Kerry. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is following a standard semaglutide initiation protocol, using the recommended 0.

The reason this review is not generic is the source wording and the canonical claim label "glp1 here i am awkwardly explaining the step by step of my third." In this clip, the useful excerpt is: "Come do my third dose of ozumbic with me." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Injection site rotation should happen every injection, not every two weeks.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is following a standard semaglutide initiation protocol, using the recommended 0.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is following a standard semaglutide initiation protocol, using the recommended 0.25 mg weekly starting dose before escalating to 0.5 mg at week five, consistent with the FDA-approved Ozempic dosing schedule. The hashtag use of #compoundsemaglutide alongside #ozempic introduces uncertainty about whether the product shown is a regulated branded pen or a compounded formulation, which carry different regulatory and quality assurance considerations. Injection technique is largely appropriate, though the described two-week site alternation interval is less frequent than most clinical guidance recommends for preventing lipohypertrophy.
  • The 0.25 mg weekly starting dose is not a therapeutic weight-loss dose. The SUSTAIN-1 trial (Sorli et al., 2017, Lancet Diabetes and Endocrinology) showed meaningful glycemic and weight effects begin at 0.5 mg and above.
  • Injection site rotation should happen every injection, not every two weeks. Repeated injection into the same spot can cause lipohypertrophy, which reduces drug absorption unpredictably.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The 0.25 mg weekly starting dose is not a therapeutic weight-loss dose. The SUSTAIN-1 trial (Sorli et al., 2017, Lancet Diabetes and Endocrinology) showed meaningful glycemic and weight effects begin at 0.5 mg and above.
  • Injection site rotation should happen every injection, not every two weeks. Repeated injection into the same spot can cause lipohypertrophy, which reduces drug absorption unpredictably.
  • The caption mixes 'g' and 'mg' notation. Semaglutide is dosed in milligrams. 0.25 g would equal 250 mg, a potentially dangerous misread for new injectors copying this format.
  • The FDA issued a 2024 safety communication warning that compounded semaglutide products may use different salt forms than approved drugs, which affects potency calculations and safety profiles.
  • Compounded semaglutide is not equivalent to branded Ozempic or Wegovy under FDA standards. Viewers should not assume identical handling, dosing, or pen mechanisms across products.
  • Post-injection holds of 5 to 10 seconds are supported by device guidance for subcutaneous auto-injectors and reduce the small but real risk of drug leaking back through the injection track.
  • Alcohol swabbing before self-injection is standard practice, but evidence from Sutherland et al. (2014, Diabetic Medicine) suggests it adds limited infection-prevention benefit in clean home settings.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @findingkerryagain actually say?

This video is a straightforward injection walkthrough. The creator demonstrates their third semaglutide dose, describes "clicking it to 0.25" milligrams, attaches a new needle tip, swabs the injection site with alcohol, removes the needle cap, grabs stomach tissue, injects, and holds for six extra seconds after hearing the click. No dramatic weight-loss claims. No medical advice given to viewers. Just someone showing their process.

The hashtags tell a slightly more complicated story. Tags like #compoundsemaglutide alongside #ozempic suggest the creator may be using a compounded version rather than the branded Ozempic pen, though they never state this explicitly on camera. That distinction matters clinically, even if the injection technique looks nearly identical.

Does the science back this up?

Most of what they demonstrate is consistent with standard subcutaneous injection protocol. The 0.25 mg starting dose aligns exactly with the FDA-approved Ozempic prescribing information, which recommends 0.25 mg weekly for the first four weeks as a tolerability ramp, not a therapeutic dose. The post-injection hold is also supported in practice.

The SUSTAIN clinical trial program (Marso et al., 2016, New England Journal of Medicine) established the 0.25 mg to 0.5 mg escalation schedule that became standard practice. The rationale is minimizing gastrointestinal side effects, not maximizing weight loss, at the lowest dose. Holding the pen after injection reduces the risk of medication leaking back out of the injection site, a small but real concern with subcutaneous biologics. Alcohol swabbing is widely practiced, though evidence that it reduces infection risk in home self-injection settings is actually weaker than most people assume.

What did they get wrong (or right)?

Credit where it is due: the technique itself is largely correct. New needle for each injection, alcohol prep, alternating injection sides, confirming the dose dial, holding post-click. These are all things a lot of people skip or do sloppily, and the creator does them properly.

Two things worth flagging. First, they say "I switch sides every second week." Standard guidance from most clinical protocols, including Novo Nordisk's own patient education materials, recommends rotating injection sites within the same region each week, not waiting two weeks between sides. Injecting the same area repeatedly can cause lipohypertrophy, a localized buildup of fatty tissue that impairs drug absorption. Rotating more frequently reduces that risk.

Second, the creator is on what they describe as their "last .25g dose" before moving to 0.5 mg. The notation mixing "g" and "mg" is worth noting for anyone watching. Semaglutide is dosed in milligrams, not grams. 0.25 grams would be 250 milligrams, which is an entirely different and dangerous quantity. This is almost certainly a typo in the caption, not a real error in practice, but these things get copied by viewers who are newer to injections.

What should you actually know?

The injection technique shown here is a reasonable template for beginners, with the rotation caveat above. But the bigger context is what this video does not address. The hashtag #compoundsemaglutide raises a real issue. Compounded semaglutide is not the same product as FDA-approved Ozempic or Wegovy. The FDA has issued multiple warnings about compounded semaglutide, including concerns about dosing errors, sterility, and the use of semaglutide salt forms rather than the base form used in approved drugs (FDA Drug Safety Communication, 2024).

If this creator is using a compounded product, the pen mechanism shown may differ from what viewers using other compounded formulations will encounter, since many compounded semaglutide products come in vials requiring separate syringes, not auto-injector pens. Viewers should not assume their setup matches what is shown here without confirming with their prescriber or pharmacist.

The 0.25 mg to 0.5 mg escalation shown is consistent with evidence-based titration. But dose decisions belong between a patient and a licensed clinician, not in a comment section or a TikTok caption.

Bottom line

This is one of the more technically responsible injection tutorials on GLP-1 TikTok. The creator is not making outrageous claims, not claiming to cure anything, and is demonstrating genuine care for doing this correctly. The rotation frequency advice could use adjustment, and the gram-versus-milligram notation in the caption is a real potential confusion point for a 70,000-view video. The compounded versus branded ambiguity is the most clinically significant unaddressed issue in the whole thing.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Finding Kerry · TikTok creator

70.1K views on this video

Here i am awkwardly explaining the step by step of my third ozempic injection. This is week 3 and my last .25g dose. I move up to .5mg next Tuesday! #ozempicjourney #ozempic #ozempicbeforeandafter #o

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the 0.25 mg weekly starting dose?

The 0.25 mg weekly starting dose is not a therapeutic weight-loss dose. The SUSTAIN-1 trial (Sorli et al., 2017, Lancet Diabetes and Endocrinology) showed meaningful glycemic and weight effects begin at 0.5 mg and above.

What does the video say about injection site rotation should happen every injection, not every two?

Injection site rotation should happen every injection, not every two weeks. Repeated injection into the same spot can cause lipohypertrophy, which reduces drug absorption unpredictably.

What does the video say about the caption mixes 'g'?

The caption mixes 'g' and 'mg' notation. Semaglutide is dosed in milligrams. 0.25 g would equal 250 mg, a potentially dangerous misread for new injectors copying this format.

What does the video say about the fda?

The FDA issued a 2024 safety communication warning that compounded semaglutide products may use different salt forms than approved drugs, which affects potency calculations and safety profiles.

What does the video say about compounded semaglutide?

Compounded semaglutide is not equivalent to branded Ozempic or Wegovy under FDA standards. Viewers should not assume identical handling, dosing, or pen mechanisms across products.

What does the video say about post-injection holds of 5 to 10 seconds?

Post-injection holds of 5 to 10 seconds are supported by device guidance for subcutaneous auto-injectors and reduce the small but real risk of drug leaking back through the injection track.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Finding Kerry, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.